Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1542-1548

  Broström, Christina ^a   Visco Comandini, Ubaldo ^a,b   Yun, Zhibing ^a   Sönnerborg, Anders ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b IRCCS   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ARTICLE; CLINICAL ARTICLE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS GENE; VIRUS ISOLATION;

DNA, VIRAL; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; RNA, VIRAL;

EID: 0032995567     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314757     Document Type: Article

References (15)

1. + T-cell levels. AIDS 1993;7:1159-66.
2. 2. Strathdee SA, Veugelers PJ, Page-Shafer KA, et al. Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters. AIDS 1996;10:959-65.
3. 3. Visco-Comandini U, Hultgren C, Broström C, Birk M, Kim S, Sällberg M. Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses. Clin Diagn Lab Immunol 1998; 5:463-66.
4. 4. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:201-08.
5. 5. Visco Comandini U, Yun Z, Paganelli R, et al. HIV-1 nef mutations and clinical long-term nonprogression. A molecular epidemiology study. J Hum Virol 1998;1:320-7.
6. 6. Vesanen M, Stevens CE, Taylor PE, Rubinstein P, Saksela K. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1 infected persons. J Virol 1996;70:9035-40.
7. + lym phocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
8. 8. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A. Chen IS, HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61:213-22.
9. 9. Chun TW, Carruth L, FinZi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-8.
10. 10. Comar M, Simonelli C, Zanussi S, et al. Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection. J Clin Invest 1997;100:893-903.
11. 11. Visco Comandini U, Sönnerborg A, Vahlne A, Yun Z, Quantification of HIV-1 proviral DNA from peripheral blood mononuclear cells using a high throughput four-competitor competitive PCR. J Virol Methods 1997;69: 171-80.
12. 12. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997;387:188-91.
13. 13. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch SK, Wasiak AJ. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 1990;64:2421-5.
14. 14. Huang Y, Zhang L, Ho DD. Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 1998;240:36-49.
15. 15. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-91.